Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Murat, Aladağ"'
Autor:
Mehmet Tahtacı, Emre Yıldırım, Enver Üçbilek, İlker Şen, Gülden Bilican, Zahide Şimşek, Süheyla Ayça Gümüş, Murat Aladağ, Murat Kıyıcı, Mehmet Cindoruk, Tarkan Karakan
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 35, Iss 3, Pp 161-167 (2024)
Background/Aims: Gastroenterologists have an important role in the treatment and management of comorbidities related to obesity. Assessment of gastroenterologists’ perception and attitude toward obesity was aimed in this study. Materials and Met
Externí odkaz:
https://doaj.org/article/01dedbdda6594ac3b8b32e9974090eaa
Autor:
Mesut Akarsu, Gökhan Kabaçam, Hale Gokcan, Murat Dayangac, Nilay Danis, Murat Aladağ, Elif Sertesen, Yasemin H. Balaban, Soner Onem, Zeki Karasu, Murat Kiyici, Sedat Karademir, Meral Akdogan, Murat Harputluoglu, Merve Gurakar, Genco Gençdal, Ramazan Idilman, Ilker Turan, Gupse Adali, Murat Akyildiz
Publikováno v:
Turk J Gastroenterol
The combination of hepatitis B immunoglobulin and potent nucleos(t)ide analogs after liver transplantation is considered as the standard of care for prophylaxis against hepatitis B virus recurrence. However, the recommended doses, route of administra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee71aa89f573c04821597e088fbc726
https://doi.org/10.5152/tjg.2021.21608
https://doi.org/10.5152/tjg.2021.21608
Autor:
Mustafa Dikilitas, Fatih Ozdemir, Serdar Karakas, Brian I. Carr, Ilknur Varol, Sezai Yilmaz, Murat Aladağ, Cemalettin Aydin, Bora Barut, Sukru Emre, Abuzer Dirican, Tolga Sahin, Cuneyt Kayaalp, Emrah Otan, Sami Akbulut, Sertac Usta, Dinçer Özgör, Cengiz Ara, Emine Samdanci, Veysel Ersan, Cemalettin Koc, Ramazan Kutlu, Murat Sait Dogan, Volkan Ince, Adil Baskiran, Murat Harputluoglu, Baris Sarici, Burak Isik, Fatih Gonultas, Koray Kutluturk, Harika Gozukara Bag
Publikováno v:
Journal of Gastrointestinal Cancer. 51:998-1005
Survival was examined from a Turkish liver transplant center of patients with HCC, to identify prognostic factors. Data from 215 patients who underwent predominantly live donor liver transplant for HCC at our institute over 12 years were included in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a48cf87ef38e87275d10f831c01d63f
https://doi.org/10.1007/s12029-020-00424-w
https://doi.org/10.1007/s12029-020-00424-w
Publikováno v:
Acta Medica. 51:9-14
Introductıon: HBV infection is a global public health problem. Tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) are nucleotide reverse transcriptase inhibitors (NRTIs) that are used for the treatment of CHB infection. The aim of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7d633cc78afa8025b636c9eaa4d12cc
https://doi.org/10.32552/0.actamedica.423
https://doi.org/10.32552/0.actamedica.423
Autor:
Murat Aladağ, M Harputluoglu, Ayse Selimoglu, Yahya Atayan, Ali Riza Caliskan, Sezai Yilmaz, Mehmet Ali Erdogan, U Demirel, Yilmaz Bilgic, Ramazan Dertli
Publikováno v:
Langenbeck's Archives of Surgery. 404:875-883
Studies reporting outcomes of endoscopic treatment methods in children who underwent liver transplantation (LT) is very limited. We present our outcomes, as a high-volume transplant center where endoscopic methods are preferred as the first choice in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6f19070fdc893c9a5d3ebf454d879c8
https://doi.org/10.1007/s00423-019-01804-y
https://doi.org/10.1007/s00423-019-01804-y
Autor:
Fehmi Tabak, Göktuğ Şirin, Mehmet Demir, Murat Aladağ, Şua Sümer, Behice Kurtaran, Selma Tosun, Tansu Yamazhan, İlkay Bozkurt, Yunus Gürbüz, Ayşe Batırel, Ebubekir Şenateş, Fatma Özlem Kandemir, Firdevs Topal, Hamdi Levent Doğanay, Orhan Sezgin, Reşit Mıstık, Şükran Köse, Yusuf Yılmaz, Dilara İnan, İftihar Köksal, Emine Parlak, Meral Akdoğan, Rahmet Güner
Objectives: To describe the prevalence of risk factors in patients infected with hepatitis C virus (HCV). Materials and Methods: Patients who were aged >18 years visiting outpatient clinics and diagnosed as having HCV infection were enrolled in this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c63c9d0d550bb9ad9a0e90824f10e7fb
https://hdl.handle.net/11454/78814
https://hdl.handle.net/11454/78814
Autor:
Murat Aladağ, Muhsin Murat Harputluoglu, Yahya Atayan, Mehmet Ali Erdogan, Ali Riza Caliskan, Sezai Yilmaz, Yilmaz Bilgic, Melih Karıncaoğlu, Oguzhan Yildirim, Yasir Furkan Cagin
Publikováno v:
Turk J Gastroenterol
BACKGROUND/AIMS: Although living donor liver transplantation (LDLT) has been accepted as a primary treatment for adults with end-stage liver disease, concerns about donor health have emerged. As LDLT is technically complex, it creates perioperative m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e8ed8092ed33e175580449a17a29356
https://pubmed.ncbi.nlm.nih.gov/33090097
https://pubmed.ncbi.nlm.nih.gov/33090097
Publikováno v:
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
OBJECTIVES This study investigated the efficacy of ledipasvir-sofosbuvir, a newly developed direct-acting antiviral drug combination for hepatitis C virus infection recurrence in patients who have developed cirrhosis secondary to hepatitis C virus an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebec1c16be161fb1c0527d9c00709302
https://pubmed.ncbi.nlm.nih.gov/32039667
https://pubmed.ncbi.nlm.nih.gov/32039667
Autor:
Fatema Alalkim, Benedetta Terziroli Beretta-Piccoli, Thomas Berg, Cumali Efe, Fulya Gunsar, Ellina Lytvyak, Janett Fischer, Fredrik Rorsman, Ali Riza Caliskan, Hanns-Ulrich Marschall, Kristina Önnerhag, Tugrul Purnak, Ida Henriksson, Maneerat Chayanupatkul, Claudia Coppo, Can Gonen, David Semela, Staffan Wahlin, Murat Kiyici, Ersan Ozaslan, Alexandra Heurgué-Berlot, Emma Nilsson, Alan Bonder, Koray Tascilar, Luigi Muratori, Fatih Güzelbulut, Murat Aladağ, Aldo J. Montano-Loza, Fatih Eren, Mårten Werner, Nurhan Demir, Henriette Ytting, Paolo Muratori, Thomas D. Schiano, Hirsh D. Trivedi, Eric M. Yoshida, Johanna Eliasson
EgeUn###
INTRODUCTION: Risk stratification based on biochemical variables is a useful tool for monitoring ursodeoxycholic acid (UDCA)-treated patients with primary biliary cholangitis (PBC). Several UDCA response criteria and scoring systems hav
INTRODUCTION: Risk stratification based on biochemical variables is a useful tool for monitoring ursodeoxycholic acid (UDCA)-treated patients with primary biliary cholangitis (PBC). Several UDCA response criteria and scoring systems hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa31e4c2ee652580a21988a89852b6e
http://hdl.handle.net/11452/29979
http://hdl.handle.net/11452/29979